Loading chat...
NY A06988
Bill
Status
5/9/2023
Primary Sponsor
Jonathan Jacobson
Click for details
AI Summary
-
Pharmacists may substitute a brand name epinephrine auto-injector with an alternate auto-injector containing identical active ingredients, dosage form, and strength, even if not on the official list of interchangeable products.
-
Substitution is permitted only when the prescriber has not marked the prescription "dispense as written."
-
The alternate epinephrine auto-injector must have a lower unit cost to the patient than the brand name product.
-
Pharmacists must inform the patient of the alternate option and obtain written consent before dispensing the substitute.
-
Pharmacists must counsel the patient on proper usage and operating features of the alternate epinephrine auto-injector.
Legislative Description
Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.
Last Action
referred to higher education
1/3/2024